100813-25-0Relevant academic research and scientific papers
New lipoxygenase and cholinesterase inhibitory sphingolipids from Carthamus oxyacantha
Dilshad, Muhammad,Riaz, Naheed,Saleem, Muhammad,Shafiq, Nusrat,Ashraf, Muhammad,Ismail, Tayaba,Rafiq, Hafiza Mehwish,Jabbar, Abdul
, p. 1787 - 1795 (2016)
Two new sphingolipids: oxyacanthin A [(2S,3S,4R)-2-{[(2R,5E)-2-hydroxyoctadec-5-enoyl]amino}hexaeicosane-1,3,4-triol; 1] and B [(2S,3S,4R)-2-{[(2R,5E)-2-hydroxyoctadec-5-enoyl]amino}hexaeicosane-1,3,4-triol-1-O-β-D-glucopyranoside; 2], together with 1-octacosanol, β-sitosterol, β-sitosterol 3-O-β-D-glucopyranoside and luteolin 7-O-β-glucopyranoside were isolated from the methanolic extract of the whole plant of Carthamus oxyacantha. Their structures were elucidated using1H and13C NMR spectra and 2D NMR analyses (HMQC, HMBC and COSY) in combination with mass spectrometry (EI-MS, HR-EI-MS, FAB-MS and HR-FAB-MS) experiments and in comparison with the literature data of the related compounds. Both the compounds 1 and 2 showed inhibitory potential against lipoxygenase (LOX) in a concentration-dependent manner with IC50values 83.3?±?1.3 and 245.7?±?1.1?μM, whereas compound 2 showed inhibition against enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50values 65.3?±?0.1 and 93.6?±?0.1?μM, respectively.
